KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Investing Activities (2018 - 2025)

LifeMD filings provide 8 years of Cash from Investing Activities readings, the most recent being $17.1 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 2682.37% to $17.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.9 million, a 184.23% increase, with the full-year FY2025 number at $6.9 million, up 184.23% from a year prior.
  • Cash from Investing Activities hit $17.1 million in Q4 2025 for LifeMD, up from -$3.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $17.1 million in Q4 2025 to a low of -$7.4 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was -$2.2 million (2022), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 15000.67% in 2022 and later skyrocketed 2682.37% in 2025.
  • LifeMD's Cash from Investing Activities stood at -$1.6 million in 2021, then decreased by 12.2% to -$1.8 million in 2022, then fell by 25.16% to -$2.2 million in 2023, then skyrocketed by 127.68% to $613492.0 in 2024, then skyrocketed by 2682.37% to $17.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were $17.1 million (Q4 2025), -$3.6 million (Q3 2025), and -$3.7 million (Q2 2025) per Business Quant data.